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Abstract 27 
Few studies assessed incidence and determinants of hypertension. We assessed the incidence and 28 
determinants of hypertension in a cohort of healthy adults aged 35 to 75 years living in Lausanne, 29 
Switzerland. Baseline data was collected from 2003 to 2006. Follow-ups were conducted in 2009-2012 30 
and 2014-2017. Incident hypertension, defined as a systolic BP ≥140 mm Hg or a diastolic BP ≥90 mm 31 
Hg or anti-hypertensive medication, was assessed at 1) second follow-up only; 2) first and/or second 32 
follow-up. After 10.9 years, incident hypertension was 26.8% (analysis 1, N=3299) and 30.3% (analysis 33 
2, N=3728). After multivariate adjustment, the variables associated with increased hypertension 34 
incidence were male gender [incident-rate ratio (IRR) and (95% confidence interval)]: 1.20 (1.07-1.35) 35 
and 1.24 (1.13-1.37) for analyses 1 and 2, respectively; increasing age (p for trend <0.001) and body 36 
mass index (p for trend <0.001) and history of cardiovascular disease (CVD). Being physically active was 37 
negatively associated with incident hypertension: 0.88 (0.78-0.98) and 0.92 (0.83-1.01) for analyses 1 38 
and 2, respectively. Except for male gender, these associations remained after adjusting for baseline 39 
BP levels, with incident rate ratios for physical activity of 0.86 (0.77-0.96) and 0.91 (0.83-0.99) for 40 
analyses 1 and 2, respectively. No association was found for education, alcohol consumption or 41 
smoking status. We conclude that over 10.9 years, between 1/4 and 1/3 of the Swiss population aged 42 
35 to 75 developed hypertension. Male gender, history of CVD, increasing age and higher BMI increase 43 
the risk of hypertension, while being physically active reduces the risk. 44 
Abstract word count: 250 45 
Keywords: prospective study; hypertension; incidence; Switzerland.  46 
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Introduction 47 
Hypertension is a major public health challenge given its involvement in cardiovascular 48 
diseases (CVD). Hypertension is one of the main causes of disability-adjusted life years (DALY) 49 
worldwide 1 and ranks second in Switzerland 2. Over 1 billion people have hypertension worldwide, 50 
and the prevalence is increasing 3. Hypertension is a major risk factor for cardiovascular diseases, renal 51 
failure, and retinal disorders. Several different guidelines have been published regarding the 52 
prevention and management of hypertension 4, 5. 53 
The strongest determinants of hypertension incidence are aging and obesity. Nevertheless, 54 
the importance of individual factors such as smoking 6, alcohol 7, physical activity 8 and socioeconomic 55 
status such as education 9 is less well characterized. Such information is important both from a public 56 
health and individual perspective. Furthermore, although many studies have assessed the incidence of 57 
hypertension in several countries, none has been performed in Switzerland.  58 
 The aim of this study was thus to assess the incidence of hypertension and to identify the 59 
socio-demographic and clinically-actionable risk factors of hypertension, in a sample of healthy adults 60 
aged 35 to 75 years living in Lausanne (Switzerland).  61 
Participants and methods 62 
 Recruitment 63 
The CoLaus Study (www.colaus-psycolaus.ch) is a prospective study aimed to assess the 64 
prevalence and determinants of cardiovascular risk factors in participants aged 35 to 75 years living in 65 
the city of Lausanne (Switzerland). The sampling procedure of the CoLaus study can be found 66 
elsewhere 10. Participants were included if they provided (a) written informed consent; (b) willingness 67 
to take part in the examination and to provide blood samples. 68 
Recruitment began in June 2003 and ended in May 2006, enrolling 6733 participants who 69 
underwent an interview, a physical exam, and a blood analysis. The first and second follow-ups were 70 
performed between April 2009 and September 2012 and between May 2014 and April 2017, 71 
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respectively, corresponding to an average of 5.6 and 10.9 years after the collection of baseline data, 72 
respectively. Data collected in the follow-ups was similar to the baseline examination. 73 
Blood pressure measurement 74 
At baseline and follow-ups, blood pressure (BP) and heart rate were measured thrice on the 75 
left arm after a 10 minutes rest in the seated position. A clinically validated automated oscillometric 76 
device (Omron® HEM-907, Matsusaka, Japan) was used with a standard cuff. In the case of an arm 77 
circumference ≥33 cm, a larger cuff was used. The average of the last two BP readings was used. 78 
Hypertension was defined as a systolic BP (SBP) ≥140 mm Hg or a diastolic BP (DBP) ≥90 mm Hg or 79 
presence of anti-hypertensive medication. Incident hypertension was defined as presence of 80 
hypertension at first or second follow-up among participants devoid of hypertension at baseline. 81 
Other variables 82 
All participants were examined in the morning after a fast of at least 8 hours. Personal and 83 
family history of CVD, CVRFs, and cardiovascular treatment were assessed by questionnaire. Smoking 84 
was categorized into never, former (irrespective of the time since quitting) and current. Education was 85 
categorized according to the highest educational level completed into low (primary), middle 86 
(apprenticeship), upper middle (high school), and high (university) . Self-reported alcohol consumption 87 
during the previous week was based on the number of units (i.e. a glass of wine, a can of beer or a shot 88 
of liquor) and categorized as none, 1-13, 14-34 and 35+/week. Physical activity was defined if the 89 
participant exercised at least twice per week for at least 20 minutes per session. Participants also 90 
indicated all medicines they were taking, prescribed or obtained over the counter. 91 
Body weight and height were measured using Seca® equipment (Hamburg, Germany) to the 92 
nearest 100 g and 5 mm, respectively, while participants stood shoeless in light indoor attire.  93 
Inclusion and exclusion criteria 94 
Participants were excluded if they: 1) presented with hypertension at baseline; 2) did not 95 
participate in the follow-up; and 3) had missing covariates. 96 
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Ethical considerations 97 
The institutional Ethics Committee of the University of Lausanne, which afterwards became 98 
the Ethics Commission of Canton Vaud (www.cer-vd.ch) approved the baseline CoLaus study and 99 
subsequent follow-ups. The study was performed in agreement with the Helsinki declaration and its 100 
former amendments. Informed consent was obtained from all participants. 101 
Statistical analysis 102 
Statistical analyses were conducted using Stata version 14.2 (Stata Corp, College Station, Texas, 103 
USA). 104 
Two analyses were performed focusing on incident hypertension between baseline and 1) 105 
second follow-up only, or 2) first and/or second follow-up. In each analysis, the following clinical and 106 
lifestyle determinants of incident hypertension were analyzed: gender, age, BMI, smoking, alcohol 107 
consumption, education, and physical activity. 108 
Participants characteristics were expressed as number (percentage) for categorical variables 109 
or as average ± standard deviation for continuous variables. Between-group comparisons were 110 
performed using chi-square or Fisher’s exact test for categorical variables and student’s t-test for 111 
continuous variables. As the incidence of hypertension was high (>20%), Poisson regression with 112 
robust confidence intervals was preferred to logistic regression for multivariable analysis, as the results 113 
from logistic regression might be overestimated 11. Results of the multivariable analysis were 114 
expressed as incidence rate ratio and (95% confidence interval). As some studies did 9, 12 and others 115 
did not 13, 14 adjust for baseline blood pressure, two multivariable models were used: with and without 116 
adjusting for baseline blood pressure.  117 
A sensitivity analysis was performed to take into account the fact that excluded and included 118 
participants differed significantly regarding several clinical and demographic characteristics. First, and 119 
for each analysis as defined previously, the probability of nonparticipation was computed using a lostic 120 
model with gender, age, BMI, smoking, alcohol consumption, education, physical activity, personal and 121 
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family history of CVD as the independent variables. The inverse of the probability of nonparticipation 122 
was used for weighting 15. Statistical significance was considered for p<0.05 (two-sided test). 123 
Results 124 
Characteristics of the sample  125 
The selection procedures for the two analyses are presented in Figure 1. Respectively 3299 126 
(49.0%) and 3728 (55.4%) participants were included in the first and in the second analysis. The 127 
characteristics of the included and excluded participants are provided in supplemental tables 1 and 2 128 
for the first and second analysis, respectively. Overall, excluded participants were older, more 129 
frequently men, with lower education, higher alcohol consumption, higher BMI and no physical 130 
activity. Excluded participants also had a higher prevalence of personal and family history of CVD. 131 
Incidence and determinants of incident hypertension  132 
After an average follow-up of 10.9 years, 883 (26.8%) and 1128 (30.3%) participants developed 133 
hypertension in the first and second analysis, respectively. The analysis of factors associated with 134 
incident hypertension is summarized in tables 1 (bivariate), 2 (multivariable, not adjusted for baseline 135 
blood pressure) and 3 (multivariable, adjusted for baseline blood pressure). 136 
As alcohol consumption was not associated with incident hypertension in the bivariate 137 
analysis, it was not introduced in the multivariable model. Overall, male gender, increasing age, higher 138 
BMI and personal or family history of CVD were positively associated, while being physically active was 139 
inversely associated with incident hypertension (table 2), and most of the associations remained after 140 
adjusting for baseline blood pressure (table 3). 141 
The results of the sensitivity analyses taking into account non-participation in the follow-up 142 
are summarized in supplemental tables 3 and 4. Again, male gender, increasing age, higher BMI and 143 
personal or family history of CVD were positively associated, while being physically active was inversely 144 
associated with incident hypertension (supplemental table 3). The associations for age, BMI, personal 145 
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history of CVD and physical activity remained after adjusting for baseline blood pressure 146 
(supplemental table 4). 147 
Discussion 148 
To our knowledge, this is the first study to assess incidence of hypertension in a Swiss 149 
population. Our results indicate that, over a period of 10.9 years, between one fourth and one third of 150 
the population aged 35 to 75 develops hypertension. Our results also indicate that male gender, 151 
increasing age, higher BMI and history of CVD (personal or familial) increase the risk of developing 152 
hypertension, while being physically active reduces the risk. 153 
Prevalence of hypertension 154 
One-third (35.4%) of participants was excluded at baseline due to hypertension. This 155 
prevalence is almost identical to the one found in the Bus Santé study of Geneva (34.4%) 16 and in 156 
another multi-cantonal cohort study (34.9%) 17. Overall, the prevalence of hypertension in our sample 157 
agrees with other existing data for Switzerland. 158 
Incidence of hypertension 159 
Between one fourth (26.8%) and one third (30.3%) of the sample developed hypertension after 160 
10.9 years of follow-up. Those values are comparable or lower to those reported in studies conducted 161 
for a shorter period in France (19.6% after 3 years) 14, Portugal (23.2% after 3.8 years) 9, and China 162 
(38.9% after 3.5 years) 18. Possible explanations are the rather low prevalence of obesity in the Swiss 163 
population 19 and a differing dietary intake 20 relative to other European countries, which might reduce 164 
the incidence of hypertension. Another explanation is the different economic status of the country, as 165 
it has been shown that developing countries are more affected by emerging risk factors than 166 
developed ones due to societal changes in diet and physical activity 21. Overall, our results indicate that 167 
the incidence of hypertension in the Swiss population appears to be lower than in other countries. 168 
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Determinants of incident hypertension 169 
Male gender was positively associated with incident hypertension, a finding also reported 170 
elsewhere 5, 13. Possible explanations include the protective effect of hormonal status among 171 
premenopausal women 22, a less healthy dietary intake and a lower health consciousness among men 172 
23.  173 
Increasing age was positively associated with incidence of hypertension, a finding in agreement 174 
with the literature 5. Possible explanations are lower physical activity levels and increasing BMI, 175 
although in this study the association between age and hypertension remained after adjusting for BMI 176 
categories and physical activity status. Other explanations include differences in dietary intake, or an 177 
age-dependent hardening of the vascular system 24 or worsening of kidney function 25. Overall, our 178 
results stress the need for adequate prevention of hypertension among elderly subjects. 179 
Increasing BMI was associated with increased incidence of hypertension. Indeed, several 180 
studies have shown that weight loss, either via diet or bariatric surgery, leads to a decrease in BP levels 181 
5. Hence, our results indicate that overweight or obese subjects should be motivated to lose weight, as 182 
it will reduce the risk of developing hypertension. 183 
Personal and familial history of CVD were positively associated with incident hypertension, 184 
independently of other cardiovascular risk factors such as smoking, obesity or physical activity. These 185 
findings are partly in agreement with the literature, where subjects with a family history of 186 
hypertension also had a higher risk of developing hypertension 26, 27. Possible explanations include 187 
other cardiovascular risk factors not accounted for such as dyslipidemia and diabetes 6. Alternatively, 188 
genetic markers associated with both conditions (i.e. CVD and hypertension) might also play a role 28. 189 
Our results thus suggest that subjects with personal or family history of CVD are at a higher risk of 190 
developing hypertension. 191 
Being physically active was inversely associated with incident hypertension, a finding in 192 
agreement with the literature 8. Several mechanisms have been put forward to explain this effect, such 193 
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as a decrease in heart rate and in systemic vascular resistance. Our results thus stress the need of 194 
regular physical exercise to prevent incidence of hypertension. 195 
Former smoking was associated with increased incidence of hypertension on bivariate analysis, 196 
but this association disappeared after multivariate adjustment, namely by the inclusion of BMI. This 197 
suggests that the effect of quitting smoking on incidence of hypertension is due to the frequent 198 
increase in weight after quitting smoking. Hence, subjects who quit smoking without increasing BMI 199 
have a triple benefit: no increase of body weight, no increase of BP, and no deleterious effects of 200 
smoking. 201 
Contrary to other studies 7, no association was found between alcohol consumption and 202 
incidence of hypertension. A likely explanation is the small proportion of excessive alcohol consumers 203 
in the sample, making the analyses underpowered to detect such associations. Also contrary to other 204 
studies 9, no association was found between educational level and incidence of hypertension, 205 
suggesting that, at least in this setting, the impact of education is modest. 206 
Implications for clinical practice and public health 207 
From a clinical perspective, prevention of hypertension should focus on men, the elderly and 208 
overweight/obese subjects. Subjects with personal of family history of CVD should also be 209 
recommended to regularly monitor their blood pressure levels. Measures aimed at losing weight, 210 
quitting smoking and increasing physical exercise, together with an improvement in dietary intake by 211 
reducing alcohol consumption 5 should be performed. From a public health perspective, general 212 
measures to promote healthy eating, a physically active friendly environment, and health education 213 
should be strengthened. Still, as our findings are based on observational and not on interventional 214 
data, our conclusions should be interpreted with caution. 215 
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Strengths and limitations 216 
To our knowledge, this is the first ever study assessing the incidence and socio-demographic 217 
determinants of hypertension in Switzerland. It is also based on a relatively long follow-up time (10.9 218 
years on average) while most studies relied on a 5-year follow-up 9, 14. 219 
This study has several limitations: firstly, it was based on an urban, French-speaking sample of 220 
Switzerland. Hence, it might not reflect the status of the other linguistic parts of the country. Still, both 221 
the prevalence rates and the determinants identified were in agreement with the literature, and 222 
similar findings might be expected in the other parts of Switzerland. Still, it would be interesting that 223 
such a study be conducted in the German or Italian speaking parts of Switzerland. Secondly, as the 224 
original sampling database was no longer available, we cannot compare the characteristics of 225 
responders and non-responders. Even though, only gender and age were available in the population 226 
register, so comparisons regarding socio-demographic determinants would have been limited. Thirdly, 227 
participation rate was low (6733 participants out of 19,830 invited, 34%) but in line with other 228 
European surveys (participation rates ranging between 16% and 57% for men and 31% and 74% in 229 
women) 29. Participation rate was lower than for a comparable study conducted in the canton of 230 
Geneva (55% to 65%) 16 but higher than or comparable to other Swiss national surveys that also 231 
included physical examinations: 9.7% for the Swiss Survey on Salt Intake 30 and 38% for the Swiss 232 
National nutrition survey 31. Fourthly, sample size was rather small, which might have reduced 233 
statistical power and precluded the identification of some associations such as with alcohol 234 
consumption. Still, most of the existing associations were identified. Fifthly, more women than men 235 
accepted to participate in the study, a finding in agreement with the literature 29. This might have 236 
reduced the incidence of hypertension, as women have a lower risk of developing hypertension than 237 
men 6, 9. Still, most associations remained after inverse probability weighting, suggesting that the 238 
higher prevalence of women in our sample did not distort the findings. 239 
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Conclusion 240 
 After a follow-up of 10.9 years, between one fourth and one third of the Swiss population 241 
aged 35 to 75 developed hypertension. Male gender, increasing age and higher BMI increase the risk 242 
of developing hypertension, while being physically active reduces the risk. 243 
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Figure legends 379 
Figure 1: selection procedure for the two analyses. 380 
381 
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Tables 
Table 1: comparison between participants who developed/did not develop hypertension between the baseline and 1) the second follow-up only or 2) the 
first or the second follow-up and participants who remained free of the condition, CoLaus study, Lausanne, Switzerland 
 Between baseline and second FU only  Between baseline and first or second FU  
  Normotensive Hypertensive P-value Normotensive Hypertensive P-value 
Sample size 2416 883  2600 1128  
Women 1474 (61.0) 480 (54.4) <0.001 1575 (60.6) 590 (52.3) <0.001 
Age (years) 48.1 ± 9.1 52.6 ± 10.1 <0.001 47.9 ± 9.0 52.7 ± 10.3 <0.001 
Age groups   <0.001   <0.001 
[35-44[ 1058 (43.8) 233 (26.4)  1162 (44.7) 300 (26.6)  
[45-54[ 796 (33.0) 295 (33.4)  851 (32.7) 368 (32.6)  
[55-64[ 445 (18.4) 246 (27.9)  471 (18.1) 308 (27.3)  
[65+ 117 (4.8) 109 (12.3)  116 (4.5) 152 (13.5)  
BMI (kg/m2) 24.1 ± 3.7 25.6 ± 3.8 <0.001 24.1 ± 3.7 25.8 ± 4.0 <0.001 
BMI categories   <0.001   <0.001 
Normal 1585 (65.6) 403 (45.6)  1708 (65.7) 506 (44.9)  
Overweight 674 (27.9) 384 (43.5)  729 (28.0) 488 (43.3)  
Obese 157 (6.5) 96 (10.9)  163 (6.3) 134 (11.9)  
Smoking categories   <0.001   <0.001 
Never 1028 (42.6) 331 (37.5)  1089 (41.9) 433 (38.4)  
Former 704 (29.1) 331 (37.5)  744 (28.6) 406 (36.0)  
17 
 
Current 684 (28.3) 215 (24.4)  767 (29.5) 289 (25.6)  
Alcohol consumption   0.051   0.055 
None 648 (26.8) 252 (28.5)  712 (27.4) 321 (28.5)  
1-13/week 1483 (61.4) 504 (57.1)  1563 (60.1) 639 (56.7)  
14-34/week 262 (10.8) 121 (13.7)  298 (11.5) 160 (14.2)  
35+/week 23 (1.0) 6 (0.7)  27 (1.0) 8 (0.7)  
Education categories   <0.001   <0.001 
Basic 360 (14.9) 166 (18.8)  412 (15.9) 219 (19.4)  
Apprenticeship 764 (31.6) 322 (36.5)  821 (31.6) 399 (35.4)  
High School 673 (27.9) 216 (24.5)  709 (27.3) 278 (24.7)  
University 619 (25.6) 179 (20.3)  658 (25.3) 232 (20.6)  
Physical activity   <0.001   0.016 
No 1016 (42.1) 421 (47.7)  1120 (43.1) 534 (47.3)  
Yes 1400 (58.0) 462 (52.3)  1480 (56.9) 594 (52.7)  
Personal history of CVD   <0.001   <0.001 
No 2374 (98.3) 840 (95.1)  2557 (98.4) 1070 (94.9)  
Yes 42 (1.7) 43 (4.9)  43 (1.7) 58 (5.1)  
Family history of CVD   0.002   <0.001 
No 1833 (75.9) 622 (70.4)  1993 (76.7) 796 (70.6)  
Yes 583 (24.1) 261 (29.6)  607 (23.4) 332 (29.4)  
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BMI, body mass index; CVD, cardiovascular disease; FU, follow-up. Results are expressed as number (percentage) for categorical variables or as average ± 
standard deviation for continuous variables. Between-group comparisons performed using chi-square for categorical variables and student’s t-test for 
continuous variables. 
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Table 2: Multivariable analysis without adjusting for baseline blood pressure of the factors associated 
with incident hypertension at 1) the second follow-up only or 2) at the first or the second follow-up, 
CoLaus study, Lausanne, Switzerland. 
 Between baseline and second FU 
only 
Between baseline and first or 
second FU 
Sample size 3299 3728 
Gender   
Woman 1 (ref.) 1 (ref.) 
Man 1.22 (1.08 - 1.36) 1.25 (1.13 - 1.38) 
Age groups   
[35-44[ 1 (ref.) 1 (ref.) 
[45-54[ 1.43 (1.23 - 1.66) 1.40 (1.23 - 1.60) 
[55-64[ 1.83 (1.57 - 2.14) 1.80 (1.58 - 2.06) 
[65+ 2.45 (2.04 - 2.96) 2.53 (2.17 - 2.95) 
p-value for trend <0.001 <0.001 
BMI categories   
Normal 1 (ref.) 1 (ref.) 
Overweight 1.57 (1.39 - 1.77) 1.55 (1.39 - 1.72) 
Obese 1.58 (1.32 - 1.89) 1.70 (1.47 - 1.98) 
p-value for trend <0.001 <0.001 
Smoking categories   
Never 1 (ref.) 1 (ref.) 
Former 1.17 (1.03 - 1.33) 1.11 (0.99 - 1.23) 
Current 0.95 (0.82 - 1.10) 0.95 (0.84 - 1.07) 
p-value for trend 0.521 0.418 
Education categories   
University 1 (ref.) 1 (ref.) 
High school 1.04 (0.88 - 1.23) 1.04 (0.90 - 1.20) 
Apprenticeship 1.15 (0.99 - 1.35) 1.11 (0.97 - 1.26) 
Basic 1.18 (0.99 - 1.42) 1.12 (0.96 - 1.31) 
p-value for trend 0.035 0.102 
Physically active   
No 1 (ref.) 1 (ref.) 
Yes 0.87 (0.78 - 0.98) 0.92 (0.83 - 1.01) 
Personal hist. of CVD   
No 1 (ref.) 1 (ref.) 
Yes 1.51 (1.21 - 1.90) 1.45 (1.21 - 1.74) 
Family history of CVD   
No 1 (ref.) 1 (ref.) 
Yes 1.17 (1.04 - 1.32) 1.19 (1.08 - 1.32) 
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BMI, body mass index; CVD, cardiovascular disease; FU, follow-up. Results expressed as multivariable 
adjusted incident rate ratio and (95% confidence interval). Statistical analysis conducted using 
Poisson regression adjusting for all the variables in the table.  
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Table 3: Multivariable analysis with further adjustment for baseline systolic and diastolic blood 
pressure of the factors associated with incident hypertension at 1) the second follow-up only or 2) at 
the first or the second follow-up, CoLaus study, Lausanne, Switzerland. 
 Between baseline and second FU 
only 
Between baseline and first or 
second FU 
Sample size 3299 3728 
Gender   
Woman 1 (ref.) 1 (ref.) 
Man 0.94 (0.84 - 1.05) 0.98 (0.89 - 1.08) 
Age groups   
[35-44[ 1 (ref.) 1 (ref.) 
[45-54[ 1.28 (1.11 - 1.47) 1.24 (1.10 - 1.40) 
[55-64[ 1.41 (1.21 - 1.65) 1.38 (1.21 - 1.58) 
[65+ 1.74 (1.44 - 2.11) 1.81 (1.55 - 2.11) 
p-value for trend <0.001 <0.001 
BMI categories   
Normal 1 (ref.) 1 (ref.) 
Overweight 1.33 (1.19 - 1.50) 1.32 (1.19 - 1.45) 
Obese 1.19 (1.00 - 1.42) 1.30 (1.13 - 1.50) 
p-value for trend 0.049 <0.001 
Smoking categories   
Never 1 (ref.) 1 (ref.) 
Former 1.18 (1.05 - 1.33) 1.13 (1.02 - 1.25) 
Current 1.09 (0.95 - 1.25) 1.06 (0.95 - 1.19) 
p-value for trend 0.239 0.302 
Education categories   
University 1 (ref.) 1 (ref.) 
High school 1.04 (0.89 - 1.22) 1.04 (0.91 - 1.19) 
Apprenticeship 1.10 (0.95 - 1.27) 1.07 (0.95 - 1.21) 
Basic 1.12 (0.94 - 1.33) 1.08 (0.93 - 1.25) 
p-value for trend 0.167 0.270 
Physically active   
No 1 (ref.) 1 (ref.) 
Yes 0.86 (0.77 - 0.95) 0.9 (0.82 - 0.99) 
Personal hist. of CVD   
No 1 (ref.) 1 (ref.) 
Yes 1.62 (1.31 - 1.99) 1.60 (1.35 - 1.90) 
Family history of CVD   
No 1 (ref.) 1 (ref.) 
Yes 1.12 (1.00 - 1.25) 1.14 (1.03 - 1.25) 
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BMI, body mass index; CVD, cardiovascular disease; FU, follow-up. Results expressed as multivariable 
adjusted incident rate ratio and (95% confidence interval). Statistical analysis conducted using 
Poisson regression adjusting for all the variables in the table. 
 
